Nutrition supplement improves the prognosis of patients with liver cirrhosis after TIPS

Effects of supplementation of whey + pea protein enriched compound nutritional powder and blank control on nutritional status and prognosis of patients with liver cirrhosis after TIPS: a prospective, open clinical trial

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300068535

Enrollment

Unknown

Registered

2023-02-22

Start date

2023-03-01

Completion date

Unknown

Last updated

2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cirrhosis

Interventions

Group A:whey + pea protein enriched compound nutritional powder supplementation

Group B:N/A

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age between 18-80 years old; 2. The diagnosis of liver cirrhosis is clear; 3. TIPS treatment in our hospital; 4. Informed consent, voluntary participation in this research.

Exclusion criteria

Exclusion criteria: 1. TIPS failed; 2. Severe cardiac insufficiency and renal insufficiency (eGFR 28 kg/m2 or those with severe hyperlipidemia; 5. Allergic to whey or pea protein.

Design outcomes

Primary

Measure	Time frame
Skeletal muscle index;Serological indicators;	—

Secondary

Measure	Time frame
Physical measurement index;Postoperative complications and prognosis;	—

Countries

China

Contacts

Public ContactMing Zhang

Nanjing Drum Tower Hospital of Nanjing University Medical School

ming_zhang0923@yahoo.com+86 177 0518 8925

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026